Lipoprotein effects on Abeta accumulation and degradation by microglia in vitro

G M Cole1, W Beech, S A Frautschy

  • 1Sepulveda VAMC, GRECC, and Departments of Medicine and Neurology, University of California-Los Angeles, Sepulveda 91343, USA. gmcole@UCLA.edu

Insights

High-density lipoprotein (HDL) enhances beta-amyloid (Abeta) degradation by microglia, a key process in Alzheimer's disease (AD) pathogenesis. Other lipoproteins like ApoE and ApoJ inhibit this Abeta clearance.

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Alzheimer's disease (AD) is characterized by neuroinflammation involving activated microglia and beta-amyloid (Abeta) plaques.
  • High-density lipoprotein (HDL) and apolipoproteins (ApoE, ApoJ) transport Abeta in biological fluids.

Purpose of the Study:

  • To investigate the influence of plasma HDL and lipidated ApoE/ApoJ on microglial interaction with Abeta1-42.
  • To understand the role of lipoproteins in Abeta trafficking and degradation by microglia.

Main Methods:

  • Cultured rat microglia were treated with Abeta1-42 in the presence of HDL, ApoE, or ApoJ.
  • Abeta degradation was quantified, and cellular uptake was visualized using immuno-electron microscopy.
  • Involvement of specific pathways was assessed using cytochalasin D and fucoidan.

Main Results:

  • HDL significantly increased Abeta degradation and the multimeric/monomeric Abeta ratio in a dose-dependent manner.
  • Lipidated ApoJ and ApoE decreased Abeta degradation, with ApoE effects being isoform-dependent.
  • Internalized Abeta was observed in endosomes/lysosomes, and cell-associated Abeta was found in deep invaginations.

Conclusions:

  • HDL promotes microglial clearance of Abeta, potentially mitigating plaque formation in AD.
  • ApoE and ApoJ inhibit microglial Abeta degradation, suggesting a complex role in AD pathogenesis.
  • Lipoprotein-mediated Abeta trafficking to microglia is a critical factor in Alzheimer's disease progression.

Related Concept Videos